Matteo Chiurlo

568 total citations
9 papers, 72 citations indexed

About

Matteo Chiurlo is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Matteo Chiurlo has authored 9 papers receiving a total of 72 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 4 papers in Virology and 2 papers in Emergency Medicine. Recurrent topics in Matteo Chiurlo's work include HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Matteo Chiurlo is often cited by papers focused on HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Matteo Chiurlo collaborates with scholars based in Italy and United States. Matteo Chiurlo's co-authors include Marco Ripa, Paolo Scarpellini, Andrea Mastrángelo, Antonella Castagna, Anna Danise, Robert J. Israel, Emanuela Messina, Giulio Ferrari, Maxime Barakat and Andrea Andolina and has published in prestigious journals such as AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes and Drug Design Development and Therapy.

In The Last Decade

Matteo Chiurlo

9 papers receiving 71 citations

Peers

Matteo Chiurlo

ID

EPIDE

AMB

NEURO

MB

Güle Çınar Türkiye

Ejaz Ahmed Khan Pakistan

Jeremy Roland United States

Monica Ivan United Kingdom

Mohamed Elbahnasawy Egypt

Benjamin Viala Switzerland

Daniela Carla Medeiros Silva Brazil

Samreen Sarfaraz Pakistan

Giovanni Moioli Italy

Francisco Homar Spain

Güle Çınar Türkiye

Matteo Chiurlo

37 ×0.7

ID

26 ×1.0

EPIDE

8 ×0.7

AMB

8 ×1.1

NEURO

6 ×0.9

MB

Citations per year, relative to Matteo Chiurlo Matteo Chiurlo (= 1×) peers Güle Çınar

Countries citing papers authored by Matteo Chiurlo

Since Specialization

Citations

This map shows the geographic impact of Matteo Chiurlo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matteo Chiurlo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matteo Chiurlo more than expected).

Fields of papers citing papers by Matteo Chiurlo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matteo Chiurlo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matteo Chiurlo. The network helps show where Matteo Chiurlo may publish in the future.

Co-authorship network of co-authors of Matteo Chiurlo

This figure shows the co-authorship network connecting the top 25 collaborators of Matteo Chiurlo. A scholar is included among the top collaborators of Matteo Chiurlo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matteo Chiurlo. Matteo Chiurlo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Galli, Laura, Caterina Candela, Nicola Gianotti, et al.. (2024). Outcome of Darunavir–Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological Failure. Drug Design Development and Therapy. Volume 18. 1153–1163. 1 indexed citations

2.

Farina, Francesca, Laura Galli, Matteo Chiurlo, et al.. (2024). High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies. Microorganisms. 12(1). 117–117. 3 indexed citations

3.

Canetti, Diana, Laura Galli, Silvia Nozza, et al.. (2023). Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: Efficacy and Tolerability in Clinical Practice. Drug Design Development and Therapy. Volume 17. 3697–3706. 2 indexed citations

4.

Chiurlo, Matteo, et al.. (2023). Probable West Nile Virus hepatitis: Case report. IDCases. 33. e01841–e01841. 2 indexed citations

5.

Messina, Emanuela, Anna Danise, Giulio Ferrari, et al.. (2021). Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series. Infectious Diseases and Therapy. 10(4). 2791–2804. 15 indexed citations

6.

Chiurlo, Matteo, Andrea Mastrángelo, Marco Ripa, & Paolo Scarpellini. (2021). Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes.. PubMed. 44(2). 71–83. 35 indexed citations

7.

Muccini, Camilla, Laura Galli, Matteo Chiurlo, et al.. (2021). Changes in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) Index in Treated HIV-1 Infected People on Virological Suppression Who Switched to a Different Antiretroviral Regimen. JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(1). e169–e173. 2 indexed citations

8.

Pastori, Claudia, Laura Galli, Gabriel Siracusano, et al.. (2021). Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patients. AIDS. 35(10). 1549–1559. 3 indexed citations

9.

Canetti, Diana, Raffaele Dell’Acqua, Niccolò Riccardi, et al.. (2020). SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic. 43(4). 161–165. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact